A VIRTUAL CASE - INTRODUCTION

Dr Angelo Pieris Teaching Fellow in Clinical Pharmacology & Therapeutics.

July 2011

Updated by Dr Hew Torrance, July 2013

This+is+an+audio+virtual+patient+case+study+demonstrating+the+use+of+flecainide+%0D%0ADoing+this+20+minute+module+will%3A++%0D%0A+%0D%0ADevelop+your+familarity+with+different+anti-arrythmic+medications+to+assist+you+in+thinking+of+appropriate+therapeutic+options+in+dealing+with+atrial+fibrillation.+%0D%0A+%0D%0AImprove+your+familiarity+in+dealing+generally+with+new+onset+atrial+fibrillation%2C+a+very+common+cardiac+arrythmia.+%0D%0A+%0D%0AThis+resource+builds+on+other+e-learning+modules+including+the+ones+on+adenosine%2C+beta+blockers+and+the+cardiology+virtual+patient+Sally.
This is an audio virtual patient case study demonstrating the use of flecainide Doing this 20 minute module will: Develop your familarity with different anti-arrythmic medications to assist you in thinking of appropriate therapeutic options in dealing with atrial fibrillation. Improve your familiarity in dealing generally with new onset atrial fibrillation, a very common cardiac arrythmia. This resource builds on other e-learning modules including the ones on adenosine, beta blockers and the cardiology virtual patient Sally.

The people here are entirely made-up. Any resemblance to actual persons or fictional characters is purely co-incidental. No doctors were harmed in the making of this resource.

Question

Select the best answer

Feedback
A VIRTUAL CASE - PRESENTATION

Dr Partridge meets Mr Bull in The Royal Smallville Hospital's emergency room.

To play click on the "button" with the white triangle. Duration: 4 minutes.

angelo-fleicanide-1st-half.mp3

To pause click again on the same button.

(The other button to the right starts the recording at the beginning!)

Imagine you are clerking Mr Bull.

What specific questions do you need to raise regarding:

1 His activities leading up to the presentation, 2 Symptoms, 3. Previous medical events?

Examination

When the playback is finished record your ABC assessment of this patient from what you can gather. Mention what has been omitted.

A VIRTUAL CASE - FLECAINIDE OR NOT FLECAINIDE

Mrs Partridge who has a MSc in Pharmacy is having a chat with Dr Partridge.

Listen to the pair discussing various treatment options. Try and pre-empt Mrs P's answers. Duration: 4 minutes

final-Mr-Bull.mp3

How might you have treated Mr Bull? Try and answer in regard to beta blockers and digoxin. (see other e-learning)

How might this "chat" not be acceptable behaviour in real life?

And finally here are top tips on Flecainide.

angelo-fleicanide-2nd-half-post-lobo-edit.mp3
A VIRTUAL CASE - ESSENTIAL MANAGEMENT OF ALL NEW A F
Question

UNLESS CONTRA-INDICATED ALL PATIENTS PRESENTING TO HOSPITAL WITH NEW ONSET AF SHOULD BE STARTED ON ............. ON ADMISSION TO PREVENT THROMBO-EMBOLISM FORMATION IN THE HEART AND ENABLE ELECTRICAL CARDIOVERSION TO BE CARRIED OUT LATER IF DEEMED NECESSARY

Feedback

If the patient is haemodynamically unstable the patient needs to be evaluated for electrical cardioversion immediately. So get help.

Question

SIGNS OF HAEMODYNAMIC INSTABILITY CAN BE

Feedback
THERE ARE 3 CORRECT ANSWERS
A VIRTUAL CASE - LINKS

Finished?

Why not go off and go for a run

People participating in intensive high level aerobic sports have a higher incidence of atrial fibrillation compared to those who are healthy but less vigorous...So I should have a doughnut instead? No its a bell shaped curve Stupid! Doh!

Links:

  • Adenosine module
  • Anti-coagulation modules.
  • Beta Blocker modules
  • Cardiology virual patient Sally

  • Suggested reference resources:

  • European Society of Cardiology
  • NICE
  • Goodman's Clinical Basis of Therapeutics
  • Barts & The London's very own duo Kumar & Clark's Clinical Medicine
  • Published by Queen Mary University of London. July 2011. Edited July 2013.

    Author: Dr Angelo Pieris, BA, MBBS. Teaching Fellow, St Bartholemew's & The Royal London Hospitals.

    Edited by Dr Hew Torrance MBBS, MSc, AKC. Academic Foundation Programme, Bart's Health NHS Trust.

    Reviewed by Dr Mel Lobo PhD, FRCP, Consultant in Clinical Pharmacology St Bartholemew's & The Royal London Hospitals.